Submit RFP/RFI
Submit RFP/RFI
Search
Submit RFP/RFI
Submit RFP/RFI
Search
Submit RFP/RFI
Submit RFP/RFI
Search

A diverse group of previously unrecognized human rhinoviruses are common causes of respiratory illnesses in infants

Lee WM, Kiesner C, Pappas T, Lee I, Grindle K, Jartti T, Jakiela B, Lemanske R, Shult P, Gern J
PLoS ONE
ICAC
12/31/2006
Publication

Related insights

Breaking New Ground in Food Allergy Treatment: Xolair Approval
Nicole Rogers, Associate Director, Project Management, shares a powerful perspective on what it means to be part
Read More
News
Food Allergy Research with CDISC Standards
In February 2024, the FDA approved a treatment for the reduction of allergic reactions to multiple foods
Read More
Presentation
The Importance of Relationships between CROs and Clinical Trial Sites
Read More
News
FDA approves Xolair – a breakthrough in food allergy treatment
Read More
News
Breathing New Insights: Exploring the Dynamic Connection Between Lung Function, Allergy and Wheezing in Urban Children
Cindy Visness, PhD, Rho’s Principal Research Scientist, worked with investigators on the NIAID-funded Urban Environment and Childhood
Read More
News
Implementing Patient-Centric Principles in Asthma Research
Read More
Article

© 2025 Rho, Inc. All rights reserved.

Scroll to Top